Origins of circulating endothelial cells and endothelial outgrowth from blood.

By Yi Lin, D. Weisdorf, Anna N. Solovey, R. Hebbel. Journal of Clinical Investigation, 2000

1,624 citations recorded by the source corpus.

Subfields: Cell Biology, Molecular Biology, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/e382caf3115c7cb1d1970b2c40b6ab61447677c4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

In Molecular Biology

Citations in the corpus

Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. (2002, background): “For instance, cells infused at the time of bone marrow (BM) transplantation contribute to skeletal muscle myoblasts [1,2] and endothelium [3–7] and acquire hepatic [8-10], biliary duct [8-10], lung, gut, skin epithelia [11], and neuroectoderm [12,13].”
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. (2001, methodology): “reported the endothelial outgrowth potential and kinetics of bone marrow-derived hematopoietic cells (Lin et al., 2000).”
Consensus guidelines for the use and interpretation of angiogenesis assays (2018, background): “1 3 following a sex-mismatched bone marrow transplant indicated that some of the BOEC were derived from the host, but the most proliferative cells were donor bone marrow derived [195].”
Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (2001, background): “Inhibition of VEGFR2 and Id impairs CEP motility VEGF is critical for the survival, differentiation and chemokinesis of CEPs (refs”
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration (2003, background): “or recruitment of bone marrow–derived EPCs and CEP”
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo (2001, background): “In addition to the endothelial cells that compose the vasculature, non-hematologic endothelial progenitor cells (EPCs) circulate in the bloo”
In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. (2003, background): “After transplantation of bone marrow or enriched hematopoietic stem cells, skeletal lung, gut, and skin epithelia (18), myoblasts (19, 20), cardiac myoblasts (21, 22), endothelium (23, 24), hepatic and biliary duct epithelium (14, 25, 26), or neuroectodermal cells (27, 28) of donor origin can be fou”
Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. (2000, neutral): “(64), employing sex-mismatched bone mar-”
Endothelial cell heterogeneity (2003, background): “Circulating differentiated endothelial cells have low proliferative capacity and do not participate in neovascularization, making it possible to distinguish them from the circulating endothelial precursor cells (92, 93).”
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. (2004, background): “The major proportion (>95%) of endothelial (progenitor) cells in blood originates from non–bone marrow tissues (42, 46).”
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function (2001, background): “; however, the precise nature of such endothelial precursors is not know”